Emergence of the PI3-kinase pathway as a central modulator of normal and aberrant B cell differentiation

G V Baracho1, A V Miletic, S A Omori

  • 1Program on Inflammatory Disease Research, Infectious and Inflammatory Disease Center, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037, USA.

Insights

Phosphoinositide 3-kinase (PI3K) signaling is crucial for B cell differentiation and function. New research reveals pathway specificity and identifies Foxo1 as a key target, impacting B cell malignancies and autoimmune diseases.

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • Phosphoinositide 3-kinase (PI3K) is a lipid kinase family regulating cellular processes.
  • PI3K and its antagonist PTEN have been primarily studied for their oncogenic roles.
  • PI3K signaling is vital for B lymphocyte differentiation and molecular events like V(D)J recombination.

Purpose of the Study:

  • To explore the specific roles and regulation of PI3K signaling in B cells.
  • To investigate the interplay between PI3K pathway components and their targets.
  • To connect PI3K pathway insights to B cell malignancies and autoimmune diseases.

Main Methods:

  • Review of recent studies on PI3K signaling in B lymphocytes.
  • Analysis of PI3K isoform specificity and phosphatase counter-regulation (PTEN, SHIP).
  • Examination of PI3K adaptor proteins (CD19, BCAP, TC21) and the Foxo1 transcription factor.

Main Results:

  • PI3K pathway exhibits specificity in B cells, with distinct isoform usage and phosphatase regulation.
  • PI3K adaptor proteins have revised roles, showing both shared and unique functions.
  • Foxo1 emerges as a key PI3K regulatory target, linking membrane events to transcriptional control.

Conclusions:

  • Understanding PI3K pathway regulation in B cells is critical for their differentiation and function.
  • Specific PI3K pathway components and targets, like Foxo1, offer therapeutic avenues for B cell malignancies.
  • PI3K signaling insights are relevant for managing B cell-dependent autoimmune diseases.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...